← Leaderboards
Andrew McNally
Colorado State University
$3,991,390
Attributed
$3,991,390
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,991,390 · 4
By mechanism
R01$3,225,403 · 2
S10$506,021 · 1
R35$259,966 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Pharmaceutical Chemistry”
- John Damon Chodera · Sloan-Kettering Inst Can Research$49,367,180
- Xinhua Li · Nano Terra, Inc.$23,903,965
- Alan D. Palkowitz · Indiana University Indianapolis$17,630,798
- Thomas Dick · Rbhs-New Jersey Medical School$14,469,725
- Timothy M Willson · University Of Cape Town$13,282,594
- Bruce Blough · Research Triangle Institute$12,018,268
Research focus
Pharmaceutical ChemistryProgramsSaltsPositioning AttributeDrug DiscoveryCouplingBiologicalReactionNitrogenPyridineFunctional GroupPharmaceutical PreparationsFda ApprovedIonsComplexSmall MoleculeElectronsPharmacologic SubstanceMediatingIsotopesChemistryMetalsHydrogen BondingMedicine
Grant awards (13)
A New General Strategy for Pyridine Functionalization via Dearomatized Intermediates$297,474
R01 · FY2025 · GM · contact PI
Selective Methods to Transform Pyridines and Diazines that Facilitate Medicinal Chemistry$259,966
R35 · FY2025 · GM · contact PI
A 400MHz NMR Spectrometer$506,021
S10 · FY2024 · OD · contact PI
New Chemical Process to Selectively Functionalize Pyridines, Diazines and Pharmaceuticals$310,130
R01 · FY2024 · GM · contact PI
A New General Strategy for Pyridine Functionalization via Dearomatized Intermediates$297,068
R01 · FY2024 · GM · contact PI
New Chemical Process to Selectively Functionalize Pyridines, Diazines and Pharmaceuticals$310,178
R01 · FY2023 · GM · contact PI
A New General Strategy for Pyridine Functionalization via Dearomatized Intermediates$298,143
R01 · FY2023 · GM · contact PI
A New General Strategy for Pyridine Functionalization via Dearomatized Intermediates$299,141
R01 · FY2022 · GM · contact PI
Selective Functionalization of Pyridines and Diazines via Heterocyclic Phosphonium Salts$280,461
R01 · FY2022 · GM · contact PI
Selective Functionalization of Pyridines and Diazines via Heterocyclic Phosphonium Salts$281,642
R01 · FY2021 · GM · contact PI
Selective Functionalization of Pyridines and Diazines via Heterocyclic Phosphonium Salts$282,735
R01 · FY2020 · GM · contact PI
Selective Functionalization of Pyridines and Diazines via Heterocyclic Phosphonium Salts$283,747
R01 · FY2019 · GM · contact PI
Selective Functionalization of Pyridines and Diazines via Heterocyclic Phosphonium Salts$284,684
R01 · FY2018 · GM · contact PI